Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Oct 12, 2021 8:10pm
140 Views
Post# 33999293

RE:RE:Ethics Approval for Canadian Sites

RE:RE:Ethics Approval for Canadian Sites,,,,acccchhhhh,,,it has been very clear DMcC intentionally misleads his shareholders inorder to save face and not getting rotten tomatoes thrown at him during presentations and other. He is somewhat of a coward me thinks. Especially since some AGM attendees noted in a previous meetting he had a non-conformist shareholder escorted out of this meeting. A talking head so to speak. The market has him/us figured out...we are not a credible investment in any way shape or form!!!,,,,,dead monies for years out. And by then our epigenetic platform will be out of date to newer and better technology. Best guess!!!!,,,,,and best suggestion,,,,first spike of irrational  excuberance pull the trigger,,,,,,this is my target,,,$1.15 and bingo!!!
<< Previous
Bullboard Posts
Next >>